on Heidelberg Pharma AG (isin : DE000A11QVV0)
Heidelberg Pharma Reports on the Results of the Annual General Meeting 2024
Heidelberg Pharma AG (FSE: HPHA) conducted its Annual General Meeting on June 21, 2024. Shareholders approved the proposed resolutions with significant majorities ranging from 98.35% to 99.99%.
Key decisions include the discharge of the Management Board and the Supervisory Board members for the fiscal year 2022/2023, the appointment of auditors for 2023/2024, and the creation of new Authorised Capital 2024/I. Additionally, the remuneration report was approved.
The meeting saw an 83.18% attendance in relation to the current capital stock. Comprehensive details and voting results can be accessed on the company’s website.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Heidelberg Pharma AG news